A CD4 helper T-inducer cancer vaccine (UCPVax), previously studied in non-small cell lung cancer (NSCLC), has been investigated in combination with ICI for HPV+ cancers including SCCA in VolATIL [98]. Here, CD4 is linked to cancer.